CDSCO
- Status: likely_approved
🇮🇳 Selg1 in India
Selg1 (CRIZANLIZUMAB) regulatory status in India.
Marketing authorisation
Selg1 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in India
Frequently asked questions
Is Selg1 approved in India?
Yes. CDSCO has authorised it.
Who is the marketing authorisation holder for Selg1 in India?
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.